Conflict of interest
AHAB, MIAA, SiH, CB, SB, PCE, AF, SuH, PK, LLF, OSP, AAT, CW, and ADK
have no conflicts of interest to disclose. MG received the SysPharmPedia
grant, co-financed by the Ministry of Education, Science and Sport
Slovenia (MIZS) (contract number C3330-16-500106) and funded by
Slovenian Research Agency (research core funding No. P3-0427). AHN has
received the ERANET Systems Medicine and ZonMW grant [project number:
9003035001], which was paid to the institution. MPY received funding
from ISCIII through AES and EC within the AAL framework, and the
SysPharmPedia grant from the ERACoSysMed 1st Joint Transnational Call
from the European Union under the Horizon 2020 (AC15/00015), and also
funded by grants SAF2017-83417R and PID2020-116274RB-I00 from
MICIU/AEI/10.13039/501100011033 Spanish Ministry of Science, Innovation
and Universities (outside of the submitted work), by the Ramon y Cajal
program (RYC-2015-17205) by MICIU/AEI/10.13039/501100011033 Spanish
Ministry of Science, Innovation and Universities. She also received
grant support outside of the submitted work from GlaxoSmithKline and CSL
Berhing. UP received SysPharmPedia grant, co-financed by the Ministry of
Higher Education, Science and Innovation Slovenia (MVZI) (contract
number C3330-16-500106), Slovenian Research and Innovation Agency
(research core funding No. P3-0427 and research grant No. J3-4497), and
PERMEABLE grant co-financed by the Republic of Slovenia, Ministry of
Higher Education, Science and Innovation (MVZI) (contract number
C3330-19-252012). MK received funding from the German Ministry of
Education and Research Council, the European Union, the German Ministry
of Education and Research, and the Bavarian Ministry of Health. He
received consulting fees from AstraZeneca, honoraria from EAACI,
Novartis, Nutricia, and Pari. SJHV received support from SysPharmPediA
ERANET and ZonMW, which was paid to the institution. AHM is the PI of a
public-private consortium (P4O2 (Precision Medicine for More Oxygen))
sponsored by Health Holland involving many private partners that
contribute in cash and/or in kind (AbbVie, Boehringer Ingelheim,
Breathomix, Fluidda, Ortec Logiqcare, PeXA, Philips, Quantib-U,
Smartfish, Clear, SODAQ, Thirona, Roche, TopMD, Novartis, RespiQ). She
received unrestricted research grants from GSK, Boehringer Ingelheim and
Vertex, and honoraria from Boehringer Ingelheim, AstraZeneca and GSK.
She is the chair of a DSMB of a study on BPD in neonates.